Molecular imaging strategies for drug discovery and development

Current Opinion in Chemical Biology

Volumn 10, Issue 4, 2006, Pages 334-342

  Gross, Shimon ^a   Piwnica Worms, David ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TARIQUIDAR;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; COST BENEFIT ANALYSIS; DIFFUSION WEIGHTED IMAGING; GENE IDENTIFICATION; MOLECULAR DYNAMICS; MOLECULAR IMAGING; MOLECULAR PROBE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; VALIDATION PROCESS;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; GENES, REPORTER; HUMANS; MICE; MOLECULAR PROBES; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS;

ANIMALIA;

EID: 33746058605     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbpa.2006.06.028     Document Type: Review

References (44)

1. Gross S., and Piwnica-Worms D. Spying on cancer: molecular imaging in vivo with genetically encoded reporters. Cancer Cell 7 (2005) 5-15. A detailed overview of state-of-the-art molecular imaging strategies using genetically encoded reporters.
2. Rudin M., and Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov 2 (2003) 123-131
3. Serganova I., and Blasberg R. Reporter gene imaging: potential impact on therapy. Nucl Med Biol 32 (2005) 763-780
4. Rudin M., Rausch M., and Stoeckli M. Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods. Mol Imaging Biol 7 (2005) 5-13
5. Shah K., and Weissleder R. Molecular optical imaging: applications leading to the development of present day therapeutics. NeuroRx 2 (2005) 215-225
6. Weinshilboum R., and Wang L. Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 3 (2004) 739-748
7. Weissleder R. Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2 (2002) 1-8
8. Tsien RY: Imagining imaging's future. Nat Rev Mol Cell Biol 2003, Suppl:SS16-SS21.
9. Blasberg R.G. In vivo molecular-genetic imaging: multi-modality nuclear and optical combinations. Nucl Med Biol 30 (2003) 879-888
10. 18F-labeled Paclitaxel, the authors were able to interrogate the target-specific PD of the Pgp1 modulator XR9576 in vivo.
11. Sharma V., Prior J., Belinsky M., Kruh G., and Piwnica-Worms D. Characterization of a gallium-67/gallium-68 radiopharmaceutical for SPECT and PET imaging of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug resistant tumors and at the blood-brain barrier. J Nucl Med 46 (2005) 354-364
12. Cirrito J.R., Deane R., Fagan A.M., Spinner M.L., Parsadanian M., Finn M.B., Jiang H., Prior J.L., Sagare A., Bales K.R., et al. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an alzheimer's disease mouse model. J Clin Invest 115 (2005) 3285-3290
13. 68Ga-labeled herceptin. Because HSP90 controls conformational maturation of HER2, monitoring surface levels of HER2 represents a viable strategy to analyze the PD of HSP90 inhibitors.
14. Oh P., Li Y., Yu J., Durr E., Krasinska K.M., Carver L.A., Testa J.E., and Schnitzer J.E. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429 (2004) 629-635. This study represents an excellent example of how small animal imaging is being efficiently applied to validate the pathological specificity and accessibility of molecular targets that were 'panned' from proteomic screens of diseased vs. normal tissues.
15. Padera T.P., Stoll B.R., Tooredman J.B., Capen D., di Tomaso E., and Jain R.K. Pathology: cancer cells compress intratumour vessels. Nature 427 (2004) 695
16. Weissleder R., Kelly K., Sun E.Y., Shtatland T., and Josephson L. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules. Nat Biotechnol 23 (2005) 1418-1423
17. Mahmood U., and Weissleder R. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2 (2003) 489-496
18. Jaffer F.A., Libby P., and Weissleder R. Molecular and cellular imaging of atherosclerosis: emerging applications. J Am Coll Cardiol 47 (2006) 1328-1338
19. Bullok K., and Piwnica-Worms D. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem 48 (2005) 5404-5407
20. Jiang T., Olson E., Nguyen Q., Roy M., Jennings P., and Tsien R. Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 101 (2004) 17867-17872
21. Joensuu H., Roberts P.J., Sarlomo-Rikala M., Andersson L.C., Tervahartiala P., Tuveson D., Silberman S., Capdeville R., Dimitrijevic S., Druker B., et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344 (2001) 1052-1056
22. Demetri G.D., von Mehren M., Blanke C.D., Van den Abbeele A.D., Eisenberg B., Roberts P.J., Heinrich M.C., Tuveson D.A., Singer S., Janicek M., et al. Efficacy and safety of Imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 347 (2002) 472-480
23. Van den Abbeele A. F18-FDG-PET provides early evidence of biological response to ST1571 patients with malignant gastrontestinal stromal tumors (GIST). Proc Am Soc Clin Oncol 20 (2001) 362a
24. Cullinane C., Dorow D.S., Kansara M., Conus N., Binns D., Hicks R.J., Ashman L.K., McArthur G.A., and Thomas D.M. An in vivo tumor model exploiting metabolic response as a biomarker for targeted drug development. Cancer Res 65 (2005) 9633-9636
25. Mayer-Kuckuk P., Menon L.G., Blasberg R.G., Bertino J.R., and Banerjee D. Role of reporter gene imaging in molecular and cellular biology. Biol Chem 385 (2004) 353-361
26. Luker G., Sharma V., Pica C., Prior J., Li W., and Piwnica-Worms D. Molecular imaging of protein-protein interactions: controlled expression of p53 and large T antigen fusion proteins in vivo. Cancer Res 63 (2003) 1780-1788
27. Safran M., Kim W.Y., Kung A.L., Horner J.W., DePinho R.A., and Kaelin Jr. W.G. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. Mol Imaging 2 (2003) 297-302
28. Uhrbom L., Nerio E., and Holland E.C. Dissecting tumor maintenance requirements using bioluminescence imaging of cell proliferation in a mouse glioma model. Nat Med 10 (2004) 1257-1260
29. Shachaf C.M., Kopelman A.M., Arvanitis C., Karlsson A., Beer S., Mandl S., Bachmann M.H., Borowsky A.D., Ruebner B., Cardiff R.D., et al. MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431 (2004) 1112-1117
30. Minn A.J., Kang Y., Serganova I., Gupta G.P., Giri D.D., Doubrovin M., Ponomarev V., Gerald W.L., Blasberg R., and Massague J. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest 115 (2005) 44-55
31. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., and Massague J. Genes that mediate breast cancer metastasis to lung. Nature 436 (2005) 518-524
32. Hardy J., Francis K.P., DeBoer M., Chu P., Gibbs K., and Contag C.H. Extracellular replication of listeria monocytogenes in the murine gall bladder. Science 303 (2004) 851-853
33. Yu Y.A., Shabahang S., Timiryasova T.M., Zhang Q., Beltz R., Gentschev I., Goebel W., and Szalay A.A. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 22 (2004) 313-320
34. Luker G., Bardill J., Prior J., Pica C., Piwnica-Worms D., and Leib D. Noninvasive bioluminescence imaging of herpes simplex virus type 1 infection and therapy in living mice. J Virol 76 (2002) 12149-12161
35. Penuelas I., Mazzolini G., Boan J.F., Sangro B., Marti-Climent J., Ruiz M., Ruiz J., Satyamurthy N., Qian C., Barrio J.R., et al. Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients. Gastroenterology 128 (2005) 1787-1795
36. Ciana P., Raviscioni M., Mussi P., Vegeto E., Que I., Parker M., Lowik C., and Maggi A. In vivo imaging of transcriptionally active estrogen receptors. Nat Med 9 (2003) 82-86
37. Zhang W., Purchio A.F., Chen K., Wu J., Lu L., Coffee R., Contag P.R., and West D.B. A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene. Drug Metab Dispos 31 (2003) 1054-1064
38. Xie W., Barwick J.L., Downes M., Blumberg B., Simon C.M., Nelson M.C., Neuschwander-Tetri B.A., Brunt E.M., Guzelian P.S., and Evans R.M. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406 (2000) 435-439
39. Carlsen H., Moskaug J.O., Fromm S.H., and Blomhoff R. In vivo imaging of NF-kappa B activity. J Immunol 168 (2002) 1441-1446
40. Gross S., and Piwnica-Worms D. Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Methods 2 (2005) 607-614. Note that the IκBα-FLuc reporter provides a more temporally proximal readout of NF-κB activation than conventional κB → FLuc reporter gene assays, thereby enabling the readout to coincide with the activity of pharmacological NF-κB modulators.
41. Ngo V.N., Davis R.E., Lamy L., Yu X., Zhao H., Lenz G., Lam L.T., Dave S., Yang L., Powell J., et al. A loss-of-function RNA interference screen for molecular targets in cancer. Nature 441 (2006) 106-110
42. Luker G., Pica C., Song J., Luker K., and Piwnica-Worms D. Imaging 26S proteasome activity and inhibition in living mice. Nat Med 9 (2003) 969-973
43. Safran M., Kim W.Y., O'Connell F., Flippin L., Gunzler V., Horner J.W., Depinho R.A., and Kaelin Jr. W.G. Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production. Proc Natl Acad Sci USA 103 (2006) 105-110. Another example of an elegant study showing the applicability of destabilized genetically encoded reporters for in cellulo and in vivo interrogations of novel inhibitors that act on key regulators of signaling pathways.
44. Zhang G.J., Safran M., Wei W., Sorensen E., Lassota P., Zhelev N., Neuberg D.S., Shapiro G., and Kaelin Jr. W.G. Bioluminescent imaging of Cdk2 inhibition in vivo. Nat Med 10 (2004) 643-648